Overview
- 135 inspections across 117 sites are on record.
- 340 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-05.
At a glance
Inspections
135
Sites
117
Observations
340
Career since
Feb 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genentech, Inc. | 5 Jul 2018 | Human Drugs | View 483 → |
| Silgan Unicep Packaging, LLC. | 25 May 2018 | Human Drugs | View 483 → |
| Ridge Properties, LLC | 30 Mar 2018 | Human Drugs | View 483 → |
| Dsquared Pharmaceuticals, Inc. | 13 Feb 2018 | Human Drugs | View 483 → |
| Vaishal Vora | 18 Nov 2017 | Human Drugs |
Sites inspected
Genentech, Inc.Hillsboro, United States1 insp.
Silgan Unicep Packaging, LLC.Sandpoint, United States1 insp.
Ridge Properties, LLCSalem, United States1 insp.
Dsquared Pharmaceuticals, Inc.Phoenix, United States1 insp.
Vaishal VoraAhmedabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Kathryn A Krentz10 shared
Lauren E Swantko5 shared
Julian C Hanson4 shared
Alexander M Kay4 shared
Thomas C Mclean4 shared
Peter S Kessler3 shared
Dianna D Wardlow-Dotter3 shared
Gina C Collins3 shared
Lorna F Jones3 shared
Tracy K Li2 shared
Full investigator report
Get the verbatim findings behind Gloria J Baca's 340 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site